Gsa Capital Partners LLP Heron Therapeutics, Inc. Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

A detailed history of Gsa Capital Partners LLP transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 512,736 shares of HRTX stock, worth $784,486. This represents 0.08% of its overall portfolio holdings.

Number of Shares

512,736

Previous 433,056 18.4%

Holding current value

$784,486

Previous $1.52 Million 32.72%

% of portfolio

0.08%

Previous 0.11%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$1.73 - $3.67 $137,846 - $292,425	79,680 Added 18.4%	512,736 $1.02 Million
Q2 2024 Aug 15, 2024	BUY	$2.32 - $3.86 $355,788 - $591,958	153,357 Added 54.83%	433,056 $1.52 Million
Q1 2024 May 03, 2024	SELL	$1.71 - $3.06 $102,170 - $182,831	-59,749 Reduced 17.6%	279,699 $774,000
Q4 2023 Feb 16, 2024	BUY	$0.54 - $1.82 $183,301 - $617,795	339,448 New	339,448 $577,000
Q1 2023 May 12, 2023	SELL	$1.51 - $3.25 $78,589 - $169,149	-52,046 Reduced 44.65%	64,528 $97,000
Q4 2022 Feb 13, 2023	BUY	$2.25 - $4.67 $67,758 - $140,637	30,115 Added 34.83%	116,574 $291,000
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $305,806 - $617,362	-114,965 Reduced 57.08%	86,459 $365,000
Q2 2022 Aug 09, 2022	BUY	$2.3 - $6.29 $122,249 - $334,326	53,152 Added 35.85%	201,424 $562,000
Q1 2022 May 11, 2022	BUY	$4.63 - $9.94 $527,347 - $1.13 Million	113,898 Added 331.35%	148,272 $848,000
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $17,267 - $26,056	-2,068 Reduced 5.67%	34,374 $314,000
Q3 2021 Nov 12, 2021	SELL	$10.13 - $15.0 $239,584 - $354,765	-23,651 Reduced 39.36%	36,442 $390,000
Q2 2021 Aug 05, 2021	BUY	$13.27 - $18.48 $354,627 - $493,859	26,724 Added 80.09%	60,093 $933,000
Q1 2021 May 10, 2021	BUY	$14.49 - $20.72 $483,516 - $691,405	33,369 New	33,369 $541,000
Q4 2020 Feb 03, 2021	SELL	$14.61 - $22.14 $616,205 - $933,798	-42,177 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$13.67 - $17.77 $576,559 - $749,485	42,177 New	42,177 $625,000
Q2 2020 Aug 11, 2020	SELL	$10.89 - $21.47 $440,598 - $868,654	-40,459 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$10.23 - $24.56 $131,967 - $316,824	12,900 Added 46.81%	40,459 $475,000
Q4 2019 Feb 12, 2020	BUY	$17.42 - $26.61 $480,077 - $733,344	27,559 New	27,559 $648,000

Others Institutions Holding HRTX

# of Institutions

179

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $182M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Heron Therapeutics, Inc. Transaction History